Medical Advocates
ABX464
 
Main Page

New and Noteworthy
 




 


 
ARV Investigational  Drugs Main New/Noteworthy Home Page      
Last Update:  May 17, 2017
Documents identified with this icon are in Portable Document Format (PDF) and require the Adobe Acrobat Reader 6.
New and Noteworthy
 
April 2015
 
Journal Papers, Abstracts, and Commentaries
 
General Reports
 
  Safety, Pharmacokinetics and Antiviral Activity of a Novel HIV Antiviral, ABX464, in Treatment- Naïve HIV Infected Subjects: a Phase II Randomized, Controlled Study.
 Steens JM, Scherrer D, Gineste P,  et al 
Antimicrob Agents Chemother. 2017 May 15.
 Abstract
 

Long lasting control of viral rebound with a new drug ABX464 targeting Rev - mediated viral RNA biogenesis.
 Campos N, Myburgh R, Garcel A, et al
Retrovirology. 2015 Apr 9;12(1):30.
 Abstract

 
   

ARV Investigational  Drugs Main New/Noteworthy Home Page      

ABX464